Cotización Cryo Cell - CCEL | ADVFN

US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Cryo Cell International Inc (CCEL) Cotización

Cryo Cell International Inc (CCEL)

6.7001

0.00

(0.00%)

Al cierre: 27 Septiembre 3:00PM

Delayed by 15 minutes

6.7001

0.00

( 0.00% )

Fuera de horario: -

Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Último Precio

6.7001

Postura de Compra

6.58

Postura de Venta

10.72

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

Precio Anterior

6.7001

Precio de Apertura

-

Hora

Última hora de negociación

-

Volumen financiero

-

Precio Promedio Ponderado

-

Volumen promedio (3 m)

-

Acciones en circulación

8,287,000

Rendimiento del Dividendo

-

Ratio Precio/Utilidad

-5.83

Beneficio por acción (BPA)

-1.15

turnover

32.39M

Beneficio neto

-9.52M

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the m... Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units. Mostrar más

Sector

Health & Allied Services,nec

Industria

Health & Allied Services,nec

Sitio web

www.cryo-cell.com

Sede

Dover, Delaware, USA

Fundado

-

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and...

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world’s first private cord blood bank to...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and...

Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ZCMDZhongchao Inc	US$ 2.10 (56.13%)	3.98M
CMTLComtech Telecommunications Corporation	US$ 6.34 (50.95%)	476.92k
GSIWGarden Stage Ltd	US$ 1.53 (26.45%)	3.27M
LXEHLixiang Education Holding Company Ltd	US$ 0.289 (9.06%)	51.26k
NWGLNature Wood Group Ltd	US$ 1.69 (9.03%)	100
ENSCEnsysce Biosciences Inc	US$ 0.22 (-23.61%)	68.15k
WNWMeiwu Technology Company Ltd	US$ 0.7792 (-10.62%)	709.17k
JFU9F Inc	US$ 2.07 (-10.00%)	148.85k
UPXIUpexi Inc	US$ 0.19 (-9.52%)	52.99k
WLDSWearable Devices Ltd	US$ 0.2316 (-8.78%)	11.55k
INTCIntel Corporation	US$ 23.87 (-0.17%)	5.16M
ZCMDZhongchao Inc	US$ 2.10 (56.13%)	3.98M
GSIWGarden Stage Ltd	US$ 1.53 (26.45%)	3.27M
NVDANVIDIA Corporation	US$ 121.00 (-0.33%)	2.92M
XPONExpion360 Inc	US$ 0.0706 (-2.22%)	2.59M

igotthemojo

igotthemojo 3 minutos hace

"As part of Biden-Harris Administration’s Investing in America agenda"

absolutely shameless promotion...and after 4 years, they are only now finally loosening up the purse strings...gee...wonder why?....smh

Shawonsarker84

Shawonsarker84 3 minutos hace

This is for AAPJ discussion board. Take your personal stuff somewhere else. Thank you.

I-Glow

I-Glow 3 minutos hace

Ole pumping Waxman - then you run and go into hiding.

You lied to investors to get them to invest in the Sharp garbage - looks like you were either a paid pumper or frontliaded pumped and then dumped.

IG

sunspotter

sunspotter 4 minutos hace

"I would be very grateful if ..... anyone ........... could comment on the latest T-Mobile filing opposing the motion for reconsideration?. Do they have a strong case?"

Yes. Cast iron.

And when VPLM fail to gain the reconsideration, they will appeal and lose the appeal

The Whale

The Whale 4 minutos hace

TrendTrade is right. And you live on iHub. No life loser.

getmoreshares

getmoreshares 5 minutos hace

one river was 29' higher on its flood level

vein

vein 5 minutos hace

Next week should be interesting hopefully

ChannelTrader

ChannelTrader 5 minutos hace

Glad you're safe.

Vipyr

Vipyr 6 minutos hace

Proof of the companies 2nd big lie.

DP1011

DP1011 6 minutos hace

The never ending next week. 😂

CarlCarlMcB

CarlCarlMcB 6 minutos hace

Weeeeeeeee$$$$$$$ bond holders $$$$$$$$$$$

timberwolf7

timberwolf7 7 minutos hace

Commie party really nothing more than criminals??

https://www.zerohedge.com/political/kunstler-america-headless-horseman-riding-blindly-chaos

Hence, the brainless wish roiling through the NSC, State Department, and the various shadow councils of the intel emeriti to lob

INV4

INV4 7 minutos hace

0.0046 (+15%) Nice! 😃

$PHBI

The Whale

The Whale 7 minutos hace

FrostyStar1

FrostyStar1 7 minutos hace

Looks like you are the one that needs the restraining order.

You have followed me onto every social media platform.

Creepy AF

fishhunter

fishhunter 7 minutos hace

I am in 100% agreement with you Coys. I am a huge believer in share buybacks in this type of situation. Why have so much cash sitting there doing nothing? Buy back 1.5mil shares and get the count below 10mil. It will never happen with the clownshow that is the BOD. Givens I have faith in, the o

hopester

hopester 7 minutos hace

Shows how desperate this Long is for a penny day.

The Whale

The Whale 8 minutos hace

TrendTrade is so right about you. You lost all your money this summer except for $AS*II. Now go take a poop on another stock because we are laughing our asses off.

ANTI-BAGHOLDER

ANTI-BAGHOLDER 9 minutos hace

So why didn’t it fill at that price?

marcis

marcis 9 minutos hace

Typical Dwyer action ( he’s not involved)

Make another faux run to rope in more $$$
Then wash / rinse and repeat

The ones predicting .01 by Friday are only off 40%

DesertDrifter

DesertDrifter 9 minutos hace

The watch salesman/grifter is in deep shit.

https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/461556659_8586389014752981_2407546136469114243_n.jpg?_nc_cat=101&ccb=1-7&_nc_sid=aa7b47&_nc_ohc=xLdLCC8uSiQQ7kNvgHeygpP&_nc_ht=scontent-lax3-2.xx&_nc_gid=Af5OMeS4j-4CfGAnF8Ia8e_&oh=00_AYAGpp

BIOChecker4

BIOChecker4 9 minutos hace

“Anavex 3-71 is the most potent with the fewer side effects.“

BMS is a smart company. They were acutely aware of all the clinical stage drug candidates targeting schizophrenia and other CNS diseases. If they thought 3-71 had superior safety and efficacy versus KarTX, they’d have bough

I-Glow

I-Glow 9 minutos hace

Oh, hell no I want you to keep buying.

"It's not nearly as hopeless as some would try to make us give up and sell would have us believe"

I want the true believers and Sharp Cult keep buying until it hurts - because I know how this story ends.

If Sharp had

ANTI-BAGHOLDER

ANTI-BAGHOLDER 9 minutos hace

Well why wouldn’t it?

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones